#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

IPEX syndrome Non-Hodgkin's lymphoma refractory Prostate cancer Wiskott-Aldrich syndrome Glioma Dent's disease Kaposi's sarcoma Andersen-Tawil syndrome Anti-myelin-associated glycoprotein antibodies positive Salivary gland cancer Juvenile chronic myelomonocytic leukaemia Hepatic cirrhosis Phenylketonuria Canavan disease Oesophageal squamous cell carcinoma More trials…
Learn about Rare Diseases

Hereditary optic atrophy – Diagnostics Fragile X syndrome – Trials in Disease VEXAS syndrome – Basic Information Waldenstrom’s macroglobulinaemia refractory – Diagnostics Stevens-Johnson syndrome – Diagnostics Congenital nephrogenic diabetes insipidus Medulloblastoma recurrent – Basic Information Osteosarcoma metastatic – Diagnostics Hairy cell leukaemia recurrent – Diagnostics Idiopathic pulmonary fibrosis – Life with Disease More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

AGANIRSEN R2R01 Polydextrose Mk-0616 Eliglustat Tartrate Setmelanotide [18F]Fapi-74 Metyrapone Choriogonadotropin Alfa Cefuroxime Sodium RNMB3 Sulfamethizole Aficamten Teriparatide Carvedilol Allopurinol Sodium YL201 Nomegestrol Acetate Lurasidone Acetic Acid, Glacial More therapies…

Learn about Your Condition

Hairy cell leukaemia Congenital myopathy Infantile apnoea Trisomy 21 Polycystic ovarian syndrome Thrombocytopenia Testicular germ cell cancer Congenital ureteric anomaly Endometrial cancer stage III Pyelonephritis acute Pleural mesothelioma Exposure via breast milk Huntington's disease Alagille syndrome Cataract More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Anti-myelin-associated glycoprotein associated polyneuropathy

Study on Zanubrutinib and Rituximab for Patients with IgM Monoclonal Gammopathy and MAG Antibodies-Related Polyneuropathy

Recruiting

2 1 1 1
Investigated Diseases:
- Anti-myelin-associated glycoprotein associated polyneuropathy
Investigated Drugs:
- Zanubrutinib
Study of Rituximab compared to placebo in patients with anti-MAG neuropathy who are likely to respond well to treatment

Not yet recruiting

3 1 1
Investigated Diseases:
- Anti-myelin-associated glycoprotein associated polyneuropathy
Investigated Drugs:
- Rituximab
- Sodium Chloride

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Anti-myelin-associated glycoprotein associated polyneuropathy

Study on Zanubrutinib and Rituximab for Patients with IgM Monoclonal Gammopathy and MAG Antibodies-Related Polyneuropathy

Study of Rituximab compared to placebo in patients with anti-MAG neuropathy who are likely to respond well to treatment

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies